ONCSQ (OncoSec Medical) Long-Term Debt: $1.91 Mil (As of Jan. 2023)


What is OncoSec Medical Long-Term Debt?

OncoSec Medical ONCSQ -99.00% Long-Term Debt is $1.91 Mil as of Jan. 2023.

OncoSec Medical's Long-Term Debt for the quarter that ended in Jan. 2023 was $1.91 Mil.

OncoSec Medical's quarterly Long-Term Debt stayed the same from Jul. 2022 ($0.00 Mil) to Oct. 2022 ($0.00 Mil) but then increased from Oct. 2022 ($0.00 Mil) to Jan. 2023 ($1.91 Mil).

OncoSec Medical's annual Long-Term Debt declined from Jul. 2020 ($0.48 Mil) to Jul. 2021 ($0.00 Mil) but then stayed the same from Jul. 2021 ($0.00 Mil) to Jul. 2022 ($0.00 Mil).

OncoSec Medical  (OTCPK:ONCSQ) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

OncoSec Medical Long-Term Debt Related Terms

OncoSec Medical Long-Term Debt Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Long-Term Debt Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.48 0.00 0.00

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.91
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $1.91 Mil mean?
OncoSec Medical (ONCSQ) has a Long-Term Debt of $1.91 Mil as of Jan. 2023.
Is OncoSec Medical's Long-Term Debt too high?
OncoSec Medical's current Long-Term Debt is $1.91 Mil.
How does OncoSec Medical's Long-Term Debt compare to NOVNQ and USRM?
OncoSec Medical's Long-Term Debt of $1.91 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. OncoSec Medical's current Long-Term Debt is $1.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (ONCSQ) has a current Long-Term Debt of $1.91 Mil. The current Long-Term Debt is $1.91 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Long-Term Debt is $1.91 Mil as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.